MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.

Zeng Y, Yin L, Zhou J, Zeng R, Xiao Y, Black AR, Hu T, Singh PK, Yin F, Batra SK, Yu F, Chen Y, Dong J
Oncogene. 2022 Jul;41(31):3859-3875. doi: 10.1038/s41388-022-02399-3. Epub 2022 Jul 2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.